114 related articles for article (PubMed ID: 9071427)
1. Lecithinized superoxide dismutase: an inhibitor of human immunodeficiency virus replication.
Premanathan M; Nakashima H; Igarashi R; Mizushima Y; Yamada K
AIDS Res Hum Retroviruses; 1997 Mar; 13(4):283-90. PubMed ID: 9071427
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents.
Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS
AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387
[TBL] [Abstract][Full Text] [Related]
3. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
5. Activity of Cu2Zn2 superoxide dismutase against the human immunodeficiency virus type 1.
Miesel R; Mahmood N; Weser U
Redox Rep; 1995 Feb; 1(2):99-103. PubMed ID: 27405551
[TBL] [Abstract][Full Text] [Related]
6. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
Ichimura H; Levy JA
Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation and characterization of newly designed alkylamidophospholipid analogues as anti-human immunodeficiency virus type 1 agents.
Kucera LS; Iyer N; Morris-Natschke SL; Chen SY; Gumus F; Ishaq K; Herrmann DB
Antivir Chem Chemother; 1998 Mar; 9(2):157-65. PubMed ID: 9875387
[TBL] [Abstract][Full Text] [Related]
8. Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear translocation.
Zhang X; Huang SZ; Gu WG; Yang LM; Chen H; Zheng CB; Zhao YX; Wan DC; Zheng YT
Chin J Nat Med; 2014 Mar; 12(3):186-93. PubMed ID: 24702804
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro effects of AZT and extracts of Ocimum gratissimum, Ficus polita, Clausena anisata, Alchornea cordifolia, and Elaeophorbia drupifera against HIV-1 and HIV-2 infections.
Ayisi NK; Nyadedzor C
Antiviral Res; 2003 Mar; 58(1):25-33. PubMed ID: 12719004
[TBL] [Abstract][Full Text] [Related]
10. Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity.
Igarashi R; Hoshino J; Ochiai A; Morizawa Y; Mizushima Y
J Pharmacol Exp Ther; 1994 Dec; 271(3):1672-7. PubMed ID: 7996483
[TBL] [Abstract][Full Text] [Related]
11. Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro.
Pal R; Mumbauer S; Hoke G; Larocca R; Myers C; Sarngadharan MG; Stein CA
AIDS Res Hum Retroviruses; 1991 Jun; 7(6):537-43. PubMed ID: 1718343
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of lecithinized superoxide dismutase on pulmonary emphysema.
Tanaka K; Tanaka Y; Miyazaki Y; Namba T; Sato K; Aoshiba K; Azuma A; Mizushima T
J Pharmacol Exp Ther; 2011 Sep; 338(3):810-8. PubMed ID: 21665943
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
14. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
[TBL] [Abstract][Full Text] [Related]
15. Lecithinized superoxide dismutase (PC-SOD) improved spinal cord injury-induced motor dysfunction through suppression of oxidative stress and enhancement of neurotrophic factor production.
Takenaga M; Ohta Y; Tokura Y; Hamaguchi A; Nakamura M; Okano H; Igarashi R
J Control Release; 2006 Jan; 110(2):283-289. PubMed ID: 16332351
[TBL] [Abstract][Full Text] [Related]
16. The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.
Auwerx J; Stevens M; Van Rompay AR; Bird LE; Ren J; De Clercq E; Oberg B; Stammers DK; Karlsson A; Balzarini J
J Virol; 2004 Jul; 78(14):7427-37. PubMed ID: 15220416
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivative.
Okamoto M; Fujiwara M; Kodama E; Yamamoto O; Shigeta S; Mitsuya H; Konno K; Yokota T; Baba M
Antivir Chem Chemother; 1999 Mar; 10(2):71-7. PubMed ID: 10335401
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.
Witvrouw M; Pannecouque C; Switzer WM; Folks TM; De Clercq E; Heneine W
Antivir Ther; 2004 Feb; 9(1):57-65. PubMed ID: 15040537
[TBL] [Abstract][Full Text] [Related]
19. Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: transcriptional regulation of inflammatory and neurotrophic genes.
Chikawa T; Ikata T; Katoh S; Hamada Y; Kogure K; Fukuzawa K
J Neurotrauma; 2001 Jan; 18(1):93-103. PubMed ID: 11200253
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of lecithinized superoxide dismutase against colitis.
Ishihara T; Tanaka K; Tasaka Y; Namba T; Suzuki J; Ishihara T; Okamoto S; Hibi T; Takenaga M; Igarashi R; Sato K; Mizushima Y; Mizushima T
J Pharmacol Exp Ther; 2009 Jan; 328(1):152-64. PubMed ID: 18927353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
